Cancer Genetics, Inc. is an emerging leader in DNA-based cancer diagnostics and services some of the most prestigious medical institutions in the world. Our tests target cancers that are difficult to diagnose and predict treatment outcomes. These cancers include hematological, urogenital and HPV-associated cancers. We also offer a comprehensive range of non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals as well as biopharma and biotech. We have established strong research collaborations with major cancer centers such as Memorial Sloan-Kettering, The Cleveland Clinic, Mayo Clinic and the National Cancer Institute. For further information, please see www.cancergenetics.com.
Latest Results: Q1 2015 Quarterly
- Jun 30 2015 7:30 AM EDT Cancer Genetics, Inc. Awarded Largest Clinical Trial in Company History; Will Provide Comprehensive Testing for Global, Multi-Year, Multi-Center Clinical Trial in Chronic Lymphocytic Leukemia (CLL)
- Jun 1 2015 7:30 AM EDT Cancer Genetics, Inc. to Present at the Jefferies 2015 Healthcare Conference
- May 29 2015 7:30 AM EDT Cancer Genetics to Report Findings of Kidney Cancer Treatment Study From Research Collaboration at the 2015 ASCO Annual Meeting
Cancer Genetics, Inc.
201 Route 17 North
Rutherford, NJ 07070
Life Science Advisors LLC